HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Acute coronary syndrome--better risk stratification by determination of inflammatory parameters?].

AbstractBACKGROUND:
In the past years coronary atherosclerosis and plaque rupture have been characterized not only as a problem of growth of smooth vascular cells, of activated thrombocytes and coagulation but also of inflammation.
PARAMETERS OF INFLAMMATION:
Several studies have demonstrated the importance of C-reactive protein as a marker for cardiovascular complications. Also interleukin-6, tumor necrosis factor-alpha and adhesion molecules are discussed as predictors of a poor prognosis in patients with acute coronary syndromes.
RISK STRATIFICATION:
A positive troponin T test is correlated with an increased rate of early complications; thus, these patients benefit from an aggressive therapy with GP IIb/IIIa receptor antagonists and acute coronary intervention. The C-reactive protein is predictive for late complications such as restenosis, reinfarction and death due to cardiac events; these patients benefit from close controls and from an anti-inflammatory therapy with acetylsalicyclic acid and statins.
AuthorsAndreas Link, Michael Böhm, Georg Nickenig
JournalMedizinische Klinik (Munich, Germany : 1983) (Med Klin (Munich)) Vol. 97 Issue 2 Pg. 63-9 (Feb 15 2002) ISSN: 0723-5003 [Print] Germany
Vernacular TitleAkutes Koronarsyndrom--bessere Risikostratifizierung durch Bestimmung von Entzündungsparametern?
PMID11910871 (Publication Type: English Abstract, Journal Article, Review)
Chemical References
  • Cell Adhesion Molecules
  • Inflammation Mediators
  • Interleukin-6
  • Tumor Necrosis Factor-alpha
  • C-Reactive Protein
Topics
  • C-Reactive Protein (metabolism)
  • Cell Adhesion Molecules (blood)
  • Coronary Artery Disease (diagnosis, immunology)
  • Humans
  • Inflammation Mediators (blood)
  • Interleukin-6 (blood)
  • Myocardial Infarction (diagnosis, immunology)
  • Prognosis
  • Tumor Necrosis Factor-alpha (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: